Literature DB >> 11122333

Interaction of the C-terminal tail region of the metabotropic glutamate receptor 7 with the protein kinase C substrate PICK1.

O El Far1, J Airas, E Wischmeyer, R B Nehring, A Karschin, H Betz.   

Abstract

Group III metabotropic glutamate receptors (mGluRs) are highly enriched in the presynaptic terminals of glutamatergic synapses where they mediate feedback inhibition of neurotransmitter release. Here, we used the yeast two-hybrid system to identify a direct interaction of the C-terminal tail region of mGluR7 with the rat homologue of the protein kinase C substrate PICK1. This interaction is specifically mediated by the very C-terminal amino acids of the receptor and can be reconstituted in human embryonic kidney 293 cells by transfection of full-length mGluR7 and PICK1 cDNAs. Quantitative beta-galactosidase assays revealed that among the different group III mGluRs, mGluR7 is the major PICK1 binding partner although other subfamily members can also interact with PICK1. These data indicate that PDZ domain-containing proteins might contribute to the presynaptic localization of group III mGluRs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11122333     DOI: 10.1046/j.1460-9568.2000.01309.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  28 in total

1.  PICK1 is required for the control of synaptic transmission by the metabotropic glutamate receptor 7.

Authors:  J Perroy; O El Far; F Bertaso; J P Pin; H Betz; J Bockaert; L Fagni
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

Review 2.  GluR2 protein-protein interactions and the regulation of AMPA receptors during synaptic plasticity.

Authors:  Fabrice Duprat; Michael Daw; Wonil Lim; Graham Collingridge; John Isaac
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-04-29       Impact factor: 6.237

3.  Functional monoclonal antibody acts as a biased agonist by inducing internalization of metabotropic glutamate receptor 7.

Authors:  C Ullmer; S Zoffmann; B Bohrmann; H Matile; L Lindemann; Pj Flor; P Malherbe
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

4.  Cellular and subcellular mRNA localization of glutamate transporter isoforms GLT1a and GLT1b in rat brain by in situ hybridization.

Authors:  Urs V Berger; Tara M DeSilva; Weizhi Chen; Paul A Rosenberg
Journal:  J Comp Neurol       Date:  2005-11-07       Impact factor: 3.215

Review 5.  Target-cell-dependent plasticity within the mossy fibre-CA3 circuit reveals compartmentalized regulation of presynaptic function at divergent release sites.

Authors:  Kenneth A Pelkey; Chris J McBain
Journal:  J Physiol       Date:  2007-12-13       Impact factor: 5.182

6.  Corequirement of PICK1 binding and PKC phosphorylation for stable surface expression of the metabotropic glutamate receptor mGluR7.

Authors:  Young Ho Suh; Kenneth A Pelkey; Gabriela Lavezzari; Paul A Roche; Richard L Huganir; Chris J McBain; Katherine W Roche
Journal:  Neuron       Date:  2008-06-12       Impact factor: 17.173

Review 7.  Overview of glutamatergic neurotransmission in the nervous system.

Authors:  Mark J Niciu; Benjamin Kelmendi; Gerard Sanacora
Journal:  Pharmacol Biochem Behav       Date:  2011-08-26       Impact factor: 3.533

8.  PDZ binding to the BAR domain of PICK1 is elucidated by coarse-grained molecular dynamics.

Authors:  Yi He; Adam Liwo; Harel Weinstein; Harold A Scheraga
Journal:  J Mol Biol       Date:  2010-11-02       Impact factor: 5.469

9.  Different binding motifs in metabotropic glutamate receptor type 7b for filamin A, protein phosphatase 1C, protein interacting with protein kinase C (PICK) 1 and syntenin allow the formation of multimeric protein complexes.

Authors:  Ralf Enz; Cristina Croci
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

Review 10.  Metabotropic glutamate receptors: physiology, pharmacology, and disease.

Authors:  Colleen M Niswender; P Jeffrey Conn
Journal:  Annu Rev Pharmacol Toxicol       Date:  2010       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.